New Zealand markets closed

89bio, Inc. (ETNB)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.64+0.33 (+2.92%)
At close: 04:00PM EDT
11.50 -0.14 (-1.20%)
After hours: 06:36PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.09B
Enterprise value 533.79M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.02
Enterprise value/revenue N/A
Enterprise value/EBITDA -4.00

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 3-23.57%
S&P500 52-week change 327.86%
52-week high 322.93
52-week low 36.57
50-day moving average 311.00
200-day moving average 312.83

Share statistics

Avg vol (3-month) 31.37M
Avg vol (10-day) 31.36M
Shares outstanding 593.5M
Implied shares outstanding 693.5M
Float 869.47M
% held by insiders 10.89%
% held by institutions 1106.41%
Shares short (15 Mar 2024) 411.11M
Short ratio (15 Mar 2024) 46.67
Short % of float (15 Mar 2024) 413.59%
Short % of shares outstanding (15 Mar 2024) 411.88%
Shares short (prior month 15 Feb 2024) 410.58M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-23.83%
Return on equity (ttm)-41.33%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -151.15M
Net income avi to common (ttm)-142.19M
Diluted EPS (ttm)-2.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)578.87M
Total cash per share (mrq)6.19
Total debt (mrq)27.11M
Total debt/equity (mrq)5.05%
Current ratio (mrq)20.04
Book value per share (mrq)5.75

Cash flow statement

Operating cash flow (ttm)-129.19M
Levered free cash flow (ttm)-82.55M